Literature DB >> 27496422

Assessment of the Hemostatic Parameters and Platelet Function on Thromboelastometry and Impedance Aggregometry in Hemodialysis Patients Qualified for Kidney Transplantation: Preliminary Report.

J Pluta1, B Nicińska2, M Grzeszczyk3, M Kołacz2, L Jureczko2, A Kwiatkowski4, M Durlik3, J Trzebicki2.   

Abstract

BACKGROUND: Chronic kidney disease is one of the medical conditions that affect hemostasis. Patients undergoing hemodialysis present both hemorrhagic and prothrombotic tendencies. Platelet adhesion to the artificial surface of the dialyzer's membrane, blood vessel endothelial wall disruption, and quantitative and qualitative changes in clothing factors are thought to be causative agents of the above-mentioned conditions. Thromboelastometry and impedance aggregometry enable precise assessment of clot formation and platelet function abnormalities, including changes related to chronic renal failure in patients undergoing renal replacement therapy.
METHODS: A prospective study with control group was designed. The study group consisted of 17 adults with diagnosed chronic renal failure undergoing hemodialysis. The control group consisted of 13 healthy volunteers. EXTEM and FIBTEM tests in rotational thromboelastometry and TRAPtest in impedance aggregometry analyzer were performed.
RESULTS: EXTEM parameter test results were comparable between analyzed groups, whereas FIBTEM test results were significantly increased in the study group. Platelet aggregation as measured by the TRAPtests was significantly decreased in patients undergoing hemodialysis.
CONCLUSIONS: In end-stage renal disease patients undergoing hemodialysis, whole-blood clot formation is not disturbed, even though platelet dysfunction occurs. Increased fibrin clot formation reflected by FIBTEM results may compensate the observed platelet disorders. The compilation of ROTEM and Multiplate may support appropriate hemostatic control and decision-making during kidney transplantation.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27496422     DOI: 10.1016/j.transproceed.2016.02.057

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  6 in total

1.  Role of Platelets in Chronic Kidney Disease.

Authors:  Nishank Jain; Adam Corken; Amudha Kumar; Clayton Davis; Jerry Ware; John Arthur
Journal:  J Am Soc Nephrol       Date:  2021-06-17       Impact factor: 14.978

2.  Total Blood Loss After Transfemoral Amputations Is Twice the Intraoperative Loss: An Observational Cohort Study of 81 Nontraumatic Amputations.

Authors:  Christian Wied; Peter T Tengberg; Morten T Kristensen; Gitte Holm; Thomas Kallemose; Anders Troelsen; Nicolai B Foss
Journal:  Geriatr Orthop Surg Rehabil       Date:  2017-05-11

3.  Lower rate of delayed graft function is observed when epidural analgesia for living donor nephrectomy is administered.

Authors:  Wolfgang Baar; Ulrich Goebel; Hartmut Buerkle; Bernd Jaenigen; Kai Kaufmann; Sebastian Heinrich
Journal:  BMC Anesthesiol       Date:  2019-03-18       Impact factor: 2.217

4.  Multiplate Platelet Function Testing upon Emergency Room Admission Fails to Provide Useful Information in Major Trauma Patients Not on Platelet Inhibitors.

Authors:  Peter Pommer; Daniel Oberladstätter; Christoph J Schlimp; Johannes Zipperle; Wolfgang Voelckel; Christopher Lockie; Marcin Osuchowski; Herbert Schöchl
Journal:  J Clin Med       Date:  2022-05-05       Impact factor: 4.241

5.  Successful kidney transplantation normalizes platelet function.

Authors:  Claire Kennedy; Limy Wong; Donal J Sexton; Jonathan Cowman; Irene Oglesby; Martin Kenny; Peter J Conlon; Dermot Kenny
Journal:  Clin Kidney J       Date:  2018-01-17

6.  Evaluation of novel coagulation and platelet function assays in patients with chronic kidney disease.

Authors:  Alyaa Abdelmaguid; Lara N Roberts; Laura Tugores; Jennifer R Joslin; Beverley J Hunt; Kiran Parmar; Danilo Nebres; Salah S Naga; Eman S Khalil; Kate Bramham
Journal:  J Thromb Haemost       Date:  2022-02-03       Impact factor: 16.036

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.